Research programme: estradiol vaginal foam - Foamix

Drug Profile

Research programme: estradiol vaginal foam - Foamix

Alternative Names: Estradiol hemihydrate foam - Foamix

Latest Information Update: 02 Jul 2014

Price : $50

At a glance

  • Originator Foamix
  • Class Estradiol congeners; Estrenes; Small molecules
  • Mechanism of Action Estrogen receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Atrophic vaginitis

Most Recent Events

  • 02 Jul 2014 Preclinical trials in Atrophic vaginitis in Israel (Vaginal)
  • 02 Jul 2014 Estradiol vaginal foam - Foamix is available for licensing.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top